Provider of AI-generated gene expression data for biological research purposes. The company offers a platform enabling scientists to generate and analyze genomic data. It allows users to customize AI models, combine AI and experimental data, and visualize expression data. The platform supports molecular experiment design, synthetic control generation, and rare sample augmentation. It also facilitates data analysis, collaboration, and access to preprocessed public data. The company operates in the Genomics sector with additional focus on Life Sciences Tech and Life Sciences Tech. Its business model centers on Clinical Data Analysis. Founded in 2023, headquartered in Seattle, United States. The company has raised $10.0M at the Series A stage. Backed by investors including Madrona.
Synthesize Bio
Series AProvider of AI-generated gene expression data for biological research purposes. The company offers a platform enabling scientists to generate and analyze genomic data. It allows users to customize AI models, combine AI and experimental data, and visualize expression data. The platform supports molecular experiment design, synthetic control generation, and rare sample augmentation. It also facilitates data analysis,…
About
Business model
Life Sciences Tech > Research & Development > Drug Informatics > Clinical Data Analysis,
Genomics > Genomics Services > Bioinformatics,
Life Sciences Platforms and Tools > Research Services > Genomics
Team background
College Wise > University of California (Berkeley)
Institutional investors
Latest coverage
📰 See all funding news — keep up with the raises that set comps.
Investor directory
🗂️ Browse all funds in our directory — active VCs and growth investors by stage and sector.